171 related articles for article (PubMed ID: 34001241)
1. MMP-2 is a novel histone H3 N-terminal protease necessary for myogenic gene activation.
Rice JC; Weekley BH; Kanholm T; Chen Z; Lee S; Fernandez DJ; Abrahamson R; Castaldi A; Borok Z; Dynlacht BD; An W
Epigenetics Chromatin; 2021 May; 14(1):23. PubMed ID: 34001241
[TBL] [Abstract][Full Text] [Related]
2. The MMP-2 histone H3 N-terminal tail protease is selectively targeted to the transcription start sites of active genes.
Weekley BH; Rice JC
Epigenetics Chromatin; 2023 May; 16(1):16. PubMed ID: 37161413
[TBL] [Abstract][Full Text] [Related]
3. MMP-9 facilitates selective proteolysis of the histone H3 tail at genes necessary for proficient osteoclastogenesis.
Kim K; Punj V; Kim JM; Lee S; Ulmer TS; Lu W; Rice JC; An W
Genes Dev; 2016 Jan; 30(2):208-19. PubMed ID: 26744418
[TBL] [Abstract][Full Text] [Related]
4. MMP-9-dependent proteolysis of the histone H3 N-terminal tail: a critical epigenetic step in driving oncogenic transcription and colon tumorigenesis.
Shin Y; Kim S; Liang G; An W
Mol Oncol; 2024 Apr; ():. PubMed ID: 38600695
[TBL] [Abstract][Full Text] [Related]
5. H3K27me1 is essential for MMP-9-dependent H3N-terminal tail proteolysis during osteoclastogenesis.
Kim K; Shin Y; Kim J; Ulmer TS; An W
Epigenetics Chromatin; 2018 May; 11(1):23. PubMed ID: 29807539
[TBL] [Abstract][Full Text] [Related]
6. DNMT and HDAC inhibitors modulate MMP-9-dependent H3 N-terminal tail proteolysis and osteoclastogenesis.
Shin Y; Ghate NB; Moon B; Park K; Lu W; An W
Epigenetics Chromatin; 2019 Apr; 12(1):25. PubMed ID: 30992059
[TBL] [Abstract][Full Text] [Related]
7. MMP-9 drives the melanomagenic transcription program through histone H3 tail proteolysis.
Shin Y; Kim S; Ghate NB; Rhie SK; An W
Oncogene; 2022 Jan; 41(4):560-570. PubMed ID: 34785776
[TBL] [Abstract][Full Text] [Related]
8. Multifunctional roles of MT1-MMP in myofiber formation and morphostatic maintenance of skeletal muscle.
Ohtake Y; Tojo H; Seiki M
J Cell Sci; 2006 Sep; 119(Pt 18):3822-32. PubMed ID: 16926191
[TBL] [Abstract][Full Text] [Related]
9. Ubiquitin-specific protease 4 (USP4) suppresses myoblast differentiation by down regulating MyoD activity in a catalytic-independent manner.
Yun SI; Kim KK
Cell Signal; 2017 Jul; 35():48-60. PubMed ID: 28336234
[TBL] [Abstract][Full Text] [Related]
10. Differential regulation of the histone chaperone HIRA during muscle cell differentiation by a phosphorylation switch.
Yang JH; Song TY; Jo C; Park J; Lee HY; Song I; Hong S; Jung KY; Kim J; Han JW; Youn HD; Cho EJ
Exp Mol Med; 2016 Aug; 48(8):e252. PubMed ID: 27515126
[TBL] [Abstract][Full Text] [Related]
11. The histone demethylase KDM4B interacts with MyoD to regulate myogenic differentiation in C2C12 myoblast cells.
Choi JH; Song YJ; Lee H
Biochem Biophys Res Commun; 2015 Jan; 456(4):872-8. PubMed ID: 25534856
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D3 decreases myoblast fusion during the growth and increases myogenic gene expression during the differentiation phase in muscle satellite cells from Korean native beef cattle.
Lee JH; Peng DQ; Jin XC; Smith SB; Lee HG
J Anim Sci; 2023 Jan; 101():. PubMed ID: 37313716
[TBL] [Abstract][Full Text] [Related]
13. Doxycycline Inhibits IL-17-Stimulated MMP-9 Expression by Downregulating ERK1/2 Activation: Implications in Myogenic Differentiation.
Obradović H; Krstić J; Kukolj T; Trivanović D; Đorđević IO; Mojsilović S; Jauković A; Jovčić G; Bugarski D; Santibañez JF
Mediators Inflamm; 2016; 2016():2939658. PubMed ID: 28042204
[TBL] [Abstract][Full Text] [Related]
14. Histone H3 Methyltransferase Suv39h1 Prevents Myogenic Terminal Differentiation by Repressing MEF2 Activity in Muscle Cells.
Jin W; Shang Y; Peng J; Jiang S
Int J Mol Sci; 2016 Nov; 17(12):. PubMed ID: 27916793
[TBL] [Abstract][Full Text] [Related]
15. Tissue inhibitor of metalloproteinase-2 (TIMP-2) regulates myogenesis and beta1 integrin expression in vitro.
Lluri G; Langlois GD; Soloway PD; Jaworski DM
Exp Cell Res; 2008 Jan; 314(1):11-24. PubMed ID: 17678891
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase 13 is a new contributor to skeletal muscle regeneration and critical for myoblast migration.
Lei H; Leong D; Smith LR; Barton ER
Am J Physiol Cell Physiol; 2013 Sep; 305(5):C529-38. PubMed ID: 23761625
[TBL] [Abstract][Full Text] [Related]
17. NET37, a nuclear envelope transmembrane protein with glycosidase homology, is involved in myoblast differentiation.
Datta K; Guan T; Gerace L
J Biol Chem; 2009 Oct; 284(43):29666-76. PubMed ID: 19706595
[TBL] [Abstract][Full Text] [Related]
18. Tetracycline Analogs Inhibit Osteoclast Differentiation by Suppressing MMP-9-Mediated Histone H3 Cleavage.
Kim Y; Kim J; Lee H; Shin WR; Lee S; Lee J; Park JI; Jhun BH; Kim YH; Yi SJ; Kim K
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31430857
[TBL] [Abstract][Full Text] [Related]
19. Regulation of TIMP-2, MT1-MMP, and MMP-2 expression during C2C12 differentiation.
Lluri G; Jaworski DM
Muscle Nerve; 2005 Oct; 32(4):492-9. PubMed ID: 16003733
[TBL] [Abstract][Full Text] [Related]
20. HIF-1α/MMP-9 Axis Is Required in the Early Phases of Skeletal Myoblast Differentiation under Normoxia Condition In Vitro.
Chellini F; Tani A; Parigi M; Palmieri F; Garella R; Zecchi-Orlandini S; Squecco R; Sassoli C
Cells; 2023 Dec; 12(24):. PubMed ID: 38132171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
